Renaissance Technologies
QTTB icon

Renaissance Technologies’s Q32 Bio QTTB Stock Holding History

Renaissance Technologies’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.29M Sell
179,600
-27,315
-13% -$228K ﹤0.01% 1877
2026
Q1 		$1.33M Buy
206,915
+107,315
+108% +$510K ﹤0.01% 2122
2025
Q4 		$331K Buy
99,600
+52,300
+111% +$148K ﹤0.01% 2727
2025
Q3 		$93.7K Sell
47,300
-29,700
-39% -$57.1K ﹤0.01% 3262
2025
Q2 		$115K Buy
+77,000
New +$131K ﹤0.01% 3280
2024
Q4 		– Sell
-16,164
Closed -$721K – 3967
2024
Q3 		$721K Buy
16,164
+1,400
+9% +$51.4K ﹤0.01% 2618
2024
Q2 		$265K Buy
+14,764
New +$353K ﹤0.01% 2958
2024
Q1 		– Sell
-9,700
Closed -$106K – 4146
2023
Q4 		$106K Sell
9,700
-300
-3% -$4.39K ﹤0.01% 3292
2023
Q3 		$211K Sell
10,000
-6,617
-40% -$135K ﹤0.01% 3076
2023
Q2 		$265K Sell
16,617
-562
-3% -$10.1K ﹤0.01% 3182
2023
Q1 		$318K Sell
17,179
-1,330
-7% -$33.1K ﹤0.01% 3089
2022
Q4 		$420K Sell
18,509
-2,552
-12% -$67.7K ﹤0.01% 3043
2022
Q3 		$610K Buy
21,061
+7,239
+52% +$295K ﹤0.01% 2808
2022
Q2 		$490K Buy
13,822
+822
+6% +$28.1K ﹤0.01% 3175
2022
Q1 		$711K Buy
13,000
+4,889
+60% +$304K ﹤0.01% 2960
2021
Q4 		$531K Buy
+8,111
New +$787K ﹤0.01% 3047
2020
Q3 		– Sell
-5,011
Closed -$1.37M – 3756
2020
Q2 		$1.37M Buy
5,011
+2,023
+68% +$539K ﹤0.01% 2392
2020
Q1 		$836K Buy
+2,988
New +$915K ﹤0.01% 2510

Other funds holding QTTB

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.89B AUM 55.94% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies's QTTB Position: Q2 2026 in Review

Renaissance Technologies reduced its Q32 Bio (QTTB) stake by 13% in Q2 2026, selling an estimated $228K and leaving 179,600 shares worth $2.29M. The position accounts for ﹤0.01% of the portfolio, ranked #1877.

Renaissance Technologies first reported a position in QTTB in Q1 2020 and has held it in 18 quarters since. 72 funds tracked by Wall St. Rank hold QTTB as of Q2 2026.

  • Renaissance Technologies held 179,600 shares of Q32 Bio worth $2.29M as of Q2 2026.
  • Renaissance Technologies sold 27,315 Q32 Bio shares in Q2 2026, an estimated $228K.
  • Q32 Bio made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #1877 holding.
  • Renaissance Technologies first reported a position in Q32 Bio in Q1 2020 and has held it in 18 quarters since.
  • 72 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.